FDA Approves Tarlatamab-Dlle for Small Cell Lung Cancer
okay, here’s a breakdown of teh references provided, formatted for clarity:
1.FDA Approval of Tarlatamab-dlle
* Source: U.S. Food adn drug Management (FDA)
* Title: FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive-Stage Small Cell Lung Cancer
* Link: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-traditional-approval-tarlatamab-dlle-extensive-stage-small-cell-lung-cancer
2. DeLLphi-304 Clinical Trial
* Study Name: Study comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
* Identifier: NCT05740566
* Source: ClinicalTrials.gov
* Updated: October 3, 2025
* Accessed: November 19, 2025
* Link: https://www.clinicaltrials.gov/study/nct05740566
3. Pharmacy Times Article
* Author: Ferruggia, K.
* Title: The FDA Grants Accelerated Approval to Tarlatamab-dlle in Small Cell lung Cancer
* Publication: Pharmacy Times
* Date: May 17,2024
* Accessed: November 19,2025
I hope this is helpful! Let me know if you’d like me to do anything else with this information.